Abstract
Objectives
To investigate the reliability of a new in-house automatic algorithm for calculating the Magnetic Resonance Parkinsonism Index (MRPI), in a large multicentre study population of patients affected by progressive supranuclear palsy (PSP) or Parkinson’s disease (PD), and healthy controls (HC), and to compare the diagnostic accuracy of the automatic and manual MRPI values.
Methods
The study included 88 PSP patients, 234 PD patients and 117 controls. MRI was performed using both 3T and 1.5T scanners. Automatic and manual MRPI values were evaluated, and accuracy of both methods in distinguishing PSP from PD and controls was calculated.
Results
No statistical differences were found between automated and manual MRPI values in all groups. The automatic MRPI values differentiated PSP from PD with an accuracy of 95 % (manual MRPI accuracy 96 %) and 97 % (manual MRPI accuracy 100 %) for 1.5T and 3T scanners, respectively.
Conclusion
Our study showed that the new in-house automated method for MRPI calculation was highly accurate in distinguishing PSP from PD. Our automatic approach allows a widespread use of MRPI in clinical practice and in longitudinal research studies.
Key Points
• A new automatic method for calculating the MRPI is presented.
• Automatic MRPI values are in good agreement with manual values.
• Automatic MRPI can distinguish patients with PSP from patients with PD.
• The automatic method overcomes MRPI application limitations in routine practice.
• The automatic method may allow a more widespread use of MRPI.
Similar content being viewed by others
Abbreviations
- M:
-
Midbrain
- MCP:
-
Middle cerebellar peduncle
- MRPI:
-
Magnetic Resonance Parkinsonism Index
- P:
-
Pons
- PD:
-
Parkinson’s disease
- PSP:
-
Progressive supranuclear palsy
- ROC:
-
Receiver operating characteristic
- SCP:
-
Superior cerebellar peduncle
References
Hughes AJ, Daniel SE, Ben‐Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125:861–870
Osaki Y, Ben-Shlomo Y, Lees AJ et al (2004) Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord Off J Mov Disord Soc 19:181–189
Warmuth-Metz M, Naumann M, Csoti I, Solymosi L (2001) Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 58:1076–1079
Paviour DC, Price SL, Stevens JM et al (2005) Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 64:675–679
Oba H, Yagishita A, Terada H et al (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64:2050–2055
Nicoletti G, Lodi R, Condino F et al (2006) Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson’s disease and progressive supranuclear palsy. Brain J Neurol 129:2679–2687
Quattrone A, Nicoletti G, Messina D et al (2008) MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 246:214–221
Nicoletti G, Tonon C, Lodi R et al (2008) Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson’s disease. Mov Disord Off J Mov Disord Soc 23:2370–2376
Hotter A, Esterhammer R, Schocke MFH, Seppi K (2009) Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism. Mov Disord Off J Mov Disord Soc 24:S711–S720
Brooks DJ, Seppi K, Neuroimaging Working Group on MSA (2009) Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord Off J Mov Disord Soc 24:949–964
Massey LA, Jäger HR, Paviour DC et al (2013) The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology 80:1856–1861
Morelli M, Arabia G, Salsone M et al (2011) Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease. Mov Disord 26:527–533
Lehéricy S, Hartmann A, Lannuzel A et al (2010) Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy. Brain J Neurol 133:2410–2425
Hussl A, Mahlknecht P, Scherfler C et al (2010) Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson’s disease and the Parkinson variant of multiple system atrophy. Mov Disord Off J Mov Disord Soc 25:2444–2449
Morelli M, Arabia G, Novellino F et al (2011) MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study. Neurology 77:1042–1047
Mostile G, Nicoletti A, Cicero CE et al (2016) Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. doi:10.1007/s10072-016-2489-x
Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9
Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39
Fahn S, Elton R, Unified Parkinson’s Disease Rating Scale (1987) Recent developments in Parkinson’s disease II. Fahn SMC, Goldstein M, Calne DB
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
Nigro S, Cerasa A, Zito G et al (2014) Fully automated segmentation of the pons and midbrain using human T1 MR brain images. PLoS ONE 9:e85618
Lachenbruch PA, Lynch CJ (1998) Assessing screening tests: extensions of McNemar’s test. Stat Med 17:2207–2217
Longoni G, Agosta F, Kostić VS et al (2011) MRI measurements of brainstem structures in patients with Richardson’s syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson’s disease. Mov Disord Off J Mov Disord Soc 26:247–255
Righini A, Antonini A, De Notaris R et al (2004) MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 25:927–932
Kato N, Arai K, Hattori T (2003) Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 210:57–60
Cosottini M, Ceravolo R, Faggioni L et al (2007) Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 116:37–42
Gröschel K, Kastrup A, Litvan I, Schulz JB (2006) Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology 66:949–950
Morelli M, Arabia G, Messina D et al (2014) Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson’s disease. Mov Disord 29:488–495
Bensimon G, Ludolph A, Agid Y et al (2009) Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 132:156–171
Acknowledgements
The scientific guarantor of this publication is Professor Aldo Quattrone. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. No complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: cross sectional study, multicentre study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Salvatore Nigro and Gennarina Arabia contributed equally to this work.
Rights and permissions
About this article
Cite this article
Nigro, S., Arabia, G., Antonini, A. et al. Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy. Eur Radiol 27, 2665–2675 (2017). https://doi.org/10.1007/s00330-016-4622-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-016-4622-x